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Background: Alcohol use and illicit drug use peak during young adulthood (around 18–
29 years of age), but comparatively little is known about polydrug use in nationally repre-
sentative samples of young adults. Drawing on a nationally representative cross-sectional
survey (Australian National Drug Strategy Household Survey), this study examines polydrug
use patterns and associated psychosocial risk factors among young adults (n=3,333; age
19–29).
Method: The use of a broad range of licit and illicit drugs were examined, including
alcohol, tobacco, cannabis, cocaine, hallucinogens, ecstasy, ketamine, GHB, inhalants,
steroids, barbiturates, meth/amphetamines, heroin, methadone/buprenorphine, other opi-
ates, painkillers, and tranquilizers/sleeping pills. Latent class analysis was employed to
identify patterns of polydrug use.
Results: Polydrug use in this sample was best described using a 5-class solution. The
majority of young adults predominantly used alcohol only (52.3%), alcohol and tobacco
(34.18%). The other classes were cannabis, ecstasy, and licit drug use (9.4%), cannabis,
amphetamine derivative, and licit drug use (2.8%), and sedative and alcohol use (1.3%).
Young adult males with low education and/or high income were most at risk of polydrug
use.
Conclusion: Almost half of young adults reported polydrug use, highlighting the impor-
tance of post-high school screening for key risk factors and polydrug use profiles, and the
delivery of early intervention strategies targeting illicit drugs.
Keywords: young adults, polydrug use, latent class analysis, cluster, risk and protective factors, simultaneous
INTRODUCTION
Young adulthood (18–29 years) is a high risk time for the use and
misuse of licit and illicit substances, relative to other age groups
(1). Alcohol is the most common drug used (86%) in this group,
with 55% of young adult Australians drinking at levels that are at
risk of alcohol-related injury arising from a single occasion in the
past month (2). Though decreasing over recent decades, approx-
imately 24% of young Australians smoke tobacco (2). The use of
illicit drugs peaks in young adulthood, with rates two to three
times higher than that of the general population (2). The use and
misuse of individual drugs are associated with substantial costs to
individuals, communities, and health systems (3–6).
In recent years there has been increased research attention on
patterns of polydrug use [defined as the consumption of more
than one drug during a specific time period; (7)] among young
adults. Much of this research has been done on relatively small
convenience samples (e.g., street-based, drug injecting, emergency
room, and club patrons), where multiple drugs are frequently used
consecutively or simultaneously, often for their perceived counter-
acting or complementary effects (8–15). These targeted studies
are important because they highlight the near universal patterns
of polydrug use that occur in specific populations (9, 10), and the
substantially higher risks to mental and physical health faced by
polydrug users compared to single drug users (16–18). However,
polydrug use in specific populations tells us little about rates of
polydrug use in wider populations.
Comparatively few studies have examined young adult poly-
drug use based on large scale population-based samples. Extant
research has been conducted on younger Australians [less than
18 years; (19)], Latin Americans [mean age 35; (20)], adult Ameri-
can populations [mean age 46; (16)], adult populations from Great
Britain [mean age 43 years; (21)], and large scale Australian twin
registry studies [mean 30 years; (17)]. Among these studies, there
is variation in the window of time used to define polydrug use.
Some studies have defined polydrug use as the use of more than
one drug in a lifetime (16, 17, 19), in the past year (21), and in the
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past month (20). The narrower the window of time used to define
polydrug use, the closer the potential proximity of use of differ-
ent drug types. However, in large scale population studies, this
results in smaller cell sizes for individuals reporting specific com-
binations of drug use, and this creates challenges for established
procedures like latent cluster analysis, which rely on minimum cell
sizes to reliably detect clusters. In part because of these statistical
power challenges, and the inherent challenges in assessing tempo-
rally linked drug taking events in large scale surveys, most such
studies utilize wide windows of time (most commonly lifetime
prevalence) to detect polydrug use.
The first goal of the present study was to evaluate the nature and
extent of polydrug use in a nationally representative population of
Australian young adults (18–29 years of age) using two temporal
windows to define polydrug use. The first was polydrug use in the
previous year [hereafter termed concurrent polydrug use, consis-
tent with earlier research; (22)], and the second was simultaneous
use, a dimension rarely assessed in large scale population studies.
One-year temporal windows for assessing polydrug use have the
advantage of capturing developmentally sensitive periods, relative
to lifetime prevalence, but are likely to retain statistical power to
determine clusters, relative to shorter temporal windows. Simul-
taneous use potentially yields an understanding of how various
combinations of drugs are used for their synergistic properties
including the enhancement of specific effects and the suppression
of unwanted effects ones (23, 24). A key concern about polydrug
use is that the effect of individual drugs are often compounded,
and harmful physiological effects accumulate in the body (23–
26). We sought to describe the extent to which simultaneous use
characterized usage patterns in young adults with recent experi-
ence in the use of different substances. The second goal of this
study was to examine demographic and broad socio-emotional
correlates of polydrug use clusters. Compared to adolescence, the
lives of young adults often involve increased disposable income,
heightened social independence, and fewer societal restrictions
on the use of certain drugs (27, 28). In this study we explored
the association of drug use clusters with socioeconomic status
(29, 30), educational level, peer substance use (31), and mental
health (16, 21).
The present study was based on the National Drug Strategy
Household Survey (NDSHS), which is unique in that it is one of
the few nationally representative studies that enables an examina-
tion of polydrug clusters, and an exploration of simultaneous drug
use. The study employs latent class analysis (LCA), which is a prob-
abilistic method of determining the size and structure of drug use
profiles. This analytic method has rarely been used in large scale
population research on young adults, but has been extensively used
with other age groups (16, 17, 21). The study is also a rare exami-
nation of how a comprehensive range of drugs, including alcohol
and tobacco, cluster together in young Australians.
MATERIALS AND METHODS
SAMPLE
The sample consisted of 3,333 participants in the 2007 NDSHS
(32) who were aged between 19 and 29 years (42.2% males,
mean age= 23.78, SD= 3.42). Of this initial sample, 322 (9.67%)
participants were excluded due to non-response for any of the
drug-related items and four participants were excluded as they
reported using a fictitious drug. The final sample size for the
LCA was 3011. Among this sample, 292 participants had one or
more missing data in the covariates. Full information maximum
likelihood estimation was used to handle the missing data. A sup-
plementary analysis with complete cases only was conducted to
evaluate the robustness of the results.
Measures
Concurrent drug use. This measure was based on NDSHS drug
use frequencies for a broad range of drugs used in the previous
12 months. Tobacco use was assessed with the item “How often do
you now smoke cigarettes, pipes, or other tobacco products?” with
responses of “daily,”“at least weekly,”“less often than weekly,”“not
at all but I have smoked in the last 12 months,” and “not at all and
I have not smoked in the last 12 months.” These responses were
recoded as 0“No smoking in the last 12 months”and 1“Smoking in
last 12 months.” Alcohol consumption was measured using a sin-
gle, yes/no response item: “Have you had an alcoholic drink of any
kind in the last 12 months?” Yes/no response items were also used
to assess for use of painkillers, tranquilizers/sleeping pills, steroids,
barbiturates, and meth/amphetamine:“Have you used (drug type)
for non-medical purpose in the last 12 months?” Consump-
tion of all other drugs, including cannabis/marijuana, heroin,
methadone/buprenorphine, cocaine, hallucinogens, ecstasy, ket-
amine, GHB, and inhalants, was assessed using yes/no questions:
“Have you used (drug type) in the last 12 months?”
Simultaneous drug use. Simultaneous drug use was examined in
a separate series of questions in which respondents reported using
a drug in the past 12 months (except tobacco and alcohol), using
the question “Which of the following did you use at the same time,
on at least one occasion that you used (drug type)?” With a list of
possible drugs (includes alcohol but not tobacco). This question
identified pairs of drugs that are being used simultaneously at least
once in the past 12 months [similar to previous studies, e.g., Ref.
(26, 33, 34)]. To increase reliability of simultaneous drug use cod-
ing, it was coded as present only when (i) both drugs were used in
the past 12 months, and (ii) simultaneous use were also reported
in both drug types (e.g., amphetamines being used simultane-
ously with cannabis, and cannabis being used simultaneously with
amphetamines).
Demographic and psychosocial correlates. The 10-item Kessler
Psychological Distress Scale (35) was used to measure depressive
and anxiety symptoms in the past 4 weeks [e.g., about how often
did you feel tired out for no good reason? (5-point scale ranging
from 1“None”to 5“All,”alpha= 0.86)]. Peer drug use was accessed
with the item“About what proportion of your friends and acquain-
tances use any of the following? Alcohol/Tobacco/Cannabis”(same
5-point response scale), and was recoded into 0 “Less than half”
or 1 “Half or more.” General health was measured with the
item “In general, would you say your health is . . .” (1 “Excel-
lent” to 5 “Poor”). Due to the low frequency of participants
reporting poor health (n= 35, 1.16% of the analysis sample),
the categories “fair” and “poor” were combined to form a single
category. Demographic variables included in the analysis were:
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sex (0 “male,” 1 “female”); marital status (1 “never married,”
2 “widowed/divorced/separated,” 3 “married/defacto”); employ-
ment status (1 “employed/self-employed,” 2 “unemployed,” 3
“home duties,” 4 “student,” 5 “retired/unable to work/other”); high
school completion (0 “completed,” 1 “not completed”); income
levels (0 “$41,600 or above,” 1 “$13,000–41,599,” 2 “$12,999 or
below,” 3 “prefer not to say/don’t know”); socioeconomic indices
for areas (SEIFA, 1 “Least advantaged/1st quartile” to 2 “Most
advantaged/fourth quartile”= 4), and regionality (1“major cities,”
2“inner regional,”3“outer regional,”4“remote/very remote”) (36).
Procedure
There were 23,356 respondents from households across all states
and territories of Australia who participated in the NDSHS and
3,333 were in the targeted age range (between 19 and 29 years). Par-
ticipants were randomly selected using a stratified design based on
statistical local areas (36). The survey involved two modes of deliv-
ery – drop and collect (19,818 respondents) and computer-assisted
telephone interview (CATI) (3,538 respondents). For each house-
hold, the respondent was the household member aged >12 years
whose birthday was next to occur in the family. Further infor-
mation on survey procedures is available in AIHW reports (37).
The survey was approved by the Australian Institute of Health
and Welfare Ethics Committee. Informed consent was obtained
from all subjects. Access to these survey data was approved by the
Australian Social Science Data Archive and by The University of
Queensland Human Research Ethics Committee.
Analysis
To identify patterns of polydrug use, LCA was performed on
the last year use of nine drugs: alcohol, tobacco, cannabis,
ecstasy, meth/amphetamine, pain-killer, tranquilizers/sleeping
pills, cocaine, and hallucinogens. LCA is a technique that iden-
tifies sub-classes within a large population based on similarity of
response to a set of measured variables. This technique is charac-
terized by two sets of parameters: (1) The estimated proportion
of each class in the population, and (2) the probability of an
individual in a particular class using a certain drug.
Determination of number of classes was based on a num-
ber of fit criteria (38). First, the Bayesian Information Criterion
(BIC) (39), Sample Size Adjusted Bayesian Information Criterion
(SSABIC) (40), and the Akaike Information Criterion (AIC) (41)
were compared across models with different number of classes. A
lower value of these information criteria indicates a better balance
model parsimony and model fit. Second, the Lo–Mendell–Rubin
adjusted likelihood ratio test (42) was used to compare the fit
of a model with k class with a model with k-1 class. A signifi-
cant p-value (p< 0.05) from this test indicates a k class model
fits the data better than a k-1 class model. Third, the number of
significant bivariate residuals was used to access the validity of the
local independent assumption of LCA. A large number of signif-
icant bivariate residuals indicates that this assumption is severely
violated. Finally, the average posterior probabilities were used to
evaluate the classification quality. Model fitting began with a one-
class solution, and the number of classes was increased successively
up to a 6-class solution. Once the optimal number of classes was
determined, covariates were added to the LCA to examine their
associations with the latent class membership. In this study, data
was prepared with STATA 11 (43) and analyses were performed
with Mplus 6.01 (44).
RESULTS
LATENT CLASS ANALYSIS
Model fit statistics for 1–6-class solutions are presented in Table 1.
A 3-class solution attained the lowest value of BIC, and a 5-class
solution attained the lowest value of AIC and SSABIC. Results
from the LMR-LRT suggested that the fit of the 4-class model
was significantly better than a 3-class model but not worse than
the 5-class model. Simulation suggested that the performance of
SSABIC and LMR-LRT were similar and superior to other statis-
tics criteria (45, 46). SSABIC suggested the 5-class solution was
optimal but LMR-LRT suggested the 4-class solution was optimal.
Since they pointed to different solutions and other fit statistics
of these two solutions were very close, both were examined on
the basis of interpretability (44). The 4-class solution identified a
class with cannabis, amphetamine derivatives, and licit drug use
but the 5-class model subdivided this class into two – a class with
cannabis, amphetamine derivatives, and licit drug use and a class
that primarily used sedatives and alcohol. This classification was
consistent with previous findings (26). The 5-class solution was
chosen as the optimal solution as it yielded classification that was
clearly distinct and interpretable, and had adequate class sizes with
high average posterior probabilities (>0.80).
Each of the five classes was described below using the probabili-
ties of drugs use in the past 12 months (see Figure 1). For heuristic
purposes, the nomenclature adopted for each class is based on the
type and range of substances with posterior probabilities greater
than 0.65.
Class 1: Participants in this class were predominantly alcohol
users (0.80 probability of alcohol use), with a small probabil-
ity (0.10) of tobacco use and nearly zero probabilities of other
drug use. This class was labeled Alcohol only, and the prevalence
estimate of this class was 52.3% (n= 1572).
Class 2: These participants reported universal alcohol use (0.98),
high probability of tobacco use (0.66), moderate probability of
cannabis use (0.31), and negligible probabilities of other drug use
(below 0.05). This class was labeled Alcohol and tobacco, and the
prevalence estimate of this class was 34.18% (n= 1028).
Class 3: Participants in this class universally reported using alco-
hol (1.00), very high probabilities of tobacco, cannabis, and
ecstasy use (probabilities 0.70 or higher), moderate probability of
meth/amphetamine and cocaine use (0.22–0.38) and low proba-
bilities of hallucinogens and other drugs. This class was labeled
Cannabis, ecstasy, and licit drug use, and the prevalence estimate
of this class was 9.44% (n= 284).
Class 4: This class was characterized by universal use of alcohol
(0.99), very high probabilities of tobacco, cannabis, ecstasy, and
meth/amphetamine use (0.70–0.89) and moderate to high prob-
abilities of all other drug use. This class was labeled Cannabis,
amphetamine derivatives, and licit drug use, and the prevalence
estimate of this class was 2.79% (n= 83).
Class 5: These participants reported universal alcohol and tran-
quilizer use (1.00), moderate to high probabilities of tobacco,
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Table 1 | Fit statistics from 1 to 6-class models.
Class Likelihood df AIC BIC SSABIC p-Value (LMR-LRT) No. of Sig. residuals
1 −7969.24 9 15956.47 16010.55 15981.95 N/A 98
2 −6859.55 19 13757.09 13871.26 13810.89 0.00 31
3 −6718.08 29 13494.15 13668.40 13576.26 0.00 4
4 −6683.10 39 13444.20 13678.54 13554.60 0.01 0
5 −6658.02 49 13414.03 13708.46 13552.77 0.14 0
6 −6644.71 59 14307.41 13761.93 13574.46 0.15 1
Bolded text indicates the chosen model based on outlined criteria.
FIGURE 1 | Probabilities of using each drug type (in last 12 months) for the five classes identified in the latent class analysis.
cannabis, ecstasy, and pain-killer/analgesic use (0.23–0.54), and
low probabilities of using other drugs (below 0.10). This class
was labeled Sedative and alcohol use, and the prevalence estimate
of this class was 1.31% (n= 39).
Table 2 shows the odd ratios and the associated 95% confidence
intervals of covariates for class membership. Relative to the Alco-
hol class, being male, being older, not completing high school and
having more income were significantly associated with member-
ship in the class 2 (alcohol and tobacco), class 3 (cannabis, ecstasy,
and licit drug use), and class 4 (cannabis, amphetamine deriva-
tives, and licit drug use) (ps< 0.05). Although being older was
significantly associated with class 5 (Sedatives and alcohol), sex,
high school completion, and having more income were not. Young
adults without partners and not living in the regional areas were
also significant predictors of class 3 and class 4 membership. Indi-
viduals living in high socioeconomic status areas or those where
were unemployed were significantly more likely to be in class 3
(p< 0.05).
Suboptimal general health was associated with classes, 2, 3,
and 4 (ps< 0.05), whilst psychological distress was significantly
associated with the classes 4 and 5 (ps< 0.05). Both peer alcohol
and tobacco use were predictors of classes 2, 3, and 4 (ps< 0.05),
while peer cannabis use was associated with classes 2–5 (ps< 0.05).
Peer alcohol use was a stronger predictor of membership in class
4 (95% CI: 4.37–53.33) than class 2 (95% CI: 1.52–2.34) and peer
cannabis use was a stronger predictor of membership of class 4
(95% CI: 8.75–21.90) compared to all other classes.
Since there were missing data in the covariate variables and full
information maximum likelihood estimation was used to handle
the missing data, a supplementary analysis using participants with
complete cases was done. The results were essentially the same –
there were only negligible differences in the odds ratios estimates
(less than 1% difference in most of the odds ratios). Therefore,
the results obtained from full information maximum likelihood
estimation were robust.
SIMULTANEOUS DRUG USE
Results for the analysis of simultaneous use (see Table 3) indicated
that a large proportion of concurrent users engage in simultaneous
drug use, especially combined use of alcohol and cannabis (18.45%
of analysis sample). The most common other drug pairs included
alcohol – ecstasy (9.54%), alcohol – meth/amphetamine (5.91%),
cannabis – ecstasy (4.99%), and alcohol – cocaine (3.69%). The
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Table 2 | Relative risk ratio estimates and 95% confidence intervals from the multinomial logistic regression with the Alcohol class as the
reference group.
Class 2:
alcohol and
tobacco
Class 3:
cannabis,
ecstasy, and
licit drug use
Class 4:
cannabis, amphetamine
derivatives, and
licit drug use
Class 5:
sedatives and
alcohol
RRRa 95% CI RRRa 95% CI RRRa 95% CI RRRa 95% CI
Age
Continuous years 1.03* (1.01–1.05) 1.07** (1.03–1.12) 1.10* (1.02–1.18) 1.14* (1.01–1.28)
Sex (Ref: Male)
Female 0.83** (0.73–0.94) 0.69** (0.54–0.89) 0.39*** (0.25–0.61) 0.96 (0.50–1.85)
High school (Ref: Completed)
Not completed 1.44*** (1.24–1.68) 1.51** (1.13–2.01) 2.03** (1.32–3.11) 1.21 (0.51–2.87)
Marital status (Ref: Non-partnered)
Partnered 0.95 (0.82–1.09) 0.56*** (0.43–0.75) 0.45** (0.27–0.77) 0.46 (0.21–1.02)
Employment status (Ref:
Self-employed/employed for wages)
Students 0.94 (0.77–1.14) 1.09 (0.72–1.63) 1.78 (0.82–3.83) 1.15 (0.33–4.01)
Unemployed 1.25 (0.92–1.69) 2.03* (1.16–3.57) 1.72 (0.75–3.94) 1.12 (0.23–5.46)
Other 1.02 (0.83–1.26) 0.90 (0.57–1.43) 1.24 (0.59–2.61) 0.36 (0.08–1.69)
Income level (Ref: $41,600 or above)
$13,000–$41,599 0.98 (0.84–1.15) 0.79 (0.59–1.05) 0.60* (0.36–1.00) 1.14 (0.49–2.67)
$12,999 or below 0.75* (0.60–0.94) 0.49** (0.31–0.76) 0.25** (0.11–0.55) 0.29 (0.05–1.75)
Prefer not to say/don’t know 0.64*** (0.50–0.80) 0.32*** (0.19–0.53) 0.21** (0.09–0.51) 0.27 (0.05–1.55)
Socioeconomic status of area (Ref: Least
advantaged)
2nd quartile 0.94 (0.78–1.12) 1.06 (0.72–1.55) 1.04 (0.53–2.01) 1.01 (0.37–2.74)
3rd quartile 0.96 (0.81–1.14) 1.22 (0.85–1.75) 1.19 (0.65–2.20) 1.33 (0.52–3.38)
4th quartile 1.02 (0.86–1.22) 1.44* (1.02–2.05) 1.55 (0.86–2.77) 1.33 (0.49–3.64)
Remoteness (Ref: Major cities)
Inner regional 1.07 (0.91–1.26) 0.79 (0.56–1.11) 0.49* (0.27–0.90) 0.75 (0.30–1.89)
Outer regional 1.04 (0.86–1.27) 0.54*** (0.36–0.81) 0.47* (0.22–0.99) 1.20 (0.43–3.36)
Remote/very remote 0.85 (0.62–1.15) 0.46* (0.25–0.86) 0.64 (0.24–1.70) 0.50 (0.07–3.78)
Depressive symptoms
Continuous K10 scores 1.01 (1.00–1.02) 1.01 (0.99–1.04) 1.09*** (1.05–1.12) 1.10*** (1.05–1.16)
General health (Ref: Excellent)
Very good 1.15 (0.98–1.34) 0.94 (0.67–1.34) 1.05 (0.54–2.07) 1.26 (0.45–3.57)
Good 1.54*** (1.30–1.81) 1.55* (1.10–2.18) 2.29* (1.21–4.36) 2.53 (0.90–7.12)
Fair/poor 1.60*** (1.23–2.09) 1.61 (0.97–2.66) 1.94 (0.89–4.22) 1.86 (0.46–7.47)
Peer alcohol use (Ref: Less than half)
More than half 1.88*** (1.52–2.34) 3.81*** (2.02–7.18) 15.27*** (4.37–53.33) 1.93 (0.42–8.92)
Peer tobacco use (Ref: Less than half)
More than half 1.88*** (1.66–2.13) 2.02*** (1.55–2.64) 3.65*** (2.14–6.22) 1.29 (0.67–2.50)
Peer cannabis use (Ref: Less than half)
More than half 2.43*** (2.02–2.91) 8.61*** (6.56–11.31) 13.85*** (8.75–21.90) 3.45*** (1.76–6.77)
***p<0.001; **p<0.01; *p<0.05.
aRRR, relative risk ratio.
results also showed that a very high proportion of concurrent
users of two specific drugs also reported using those specific
drugs simultaneously. This was especially notable for alcohol and
cannabis, alcohol and ecstasy, and alcohol and meth/amphetamine
(greater than 90% of concurrent users were simultaneous users for
each of these drug pairs).
DISCUSSION
The primary aim of this study was to examine patterns of poly-
drug use (last 12 months) across a broad range of licit and illicit
substances in a nationally representative sample of young adults.
Over 25% of young adults in this study reported using drugs other
than alcohol in the past 12 months. A 5-class solution resulted,
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Table 3 | Percentage of participants reporting concurrent use, simultaneous use, and proportion of concurrent users who were also
simultaneous users.
Top 10 simultaneous
drug combinations
% Concurrent use
(use of these two drugs
at an time in the
last 12 months)
% Simultaneous use
(use of two specific
drugs simultaneously)
Percentage of
concurrent users
also report
simultaneous use (%)
All (%) 95% CI All (%) 95% CI
Alcohol and cannabis 20.72 (19.27, 22.17) 18.45 (17.06, 19.84) 89
Alcohol and ecstasy 10.54 (9.44, 11.64) 9.54 (8.49, 10.59) 91
Alcohol and meth/amphetamine 6.52 (5.73, 7.51) 5.91 (5.07, 6.76) 91
Cannabis and ecstasy 7.42 (6.48, 8.35) 4.99 (4.21, 5.77) 67
Cannabis and meth/amphetamine 5.02 (4.24, 5.80) 4.09 (3.38, 4.80) 81
Alcohol and cocaine 4.16 (3.44, 4.87) 3.69 (3.02, 4.37) 89
Meth/amphetamines and ecstasy 4.69 (3.93, 5.45) 3.23 (2.59, 3.86) 69
Cannabis and cocaine 3.19 (2.56, 3.82) 1.76 (1.29, 2.23) 55
Cocaine and ecstasy 3.09 (2.47, 3.71) 1.63 (1.18, 2.08) 53
Alcohol and painkillers 3.22 (2.59, 3.86) 1.50 (1.06, 1.93) 47
A participant can display more than one combination of polydrug use.
with all classes containing a very high probability of alcohol use,
and classes named by the unique feature of each cluster. The classes
were:Alcohol only (52.3%)Alcohol and tobacco (34.2%),Cannabis,
ecstasy and licit drug use (9.4%), Cannabis, amphetamine deriv-
atives, and licit drug use (2.8%), and Sedatives and alcohol use
(1.3%). Additional analysis indicated that when young adults
reported concurrent use of drug pairs (in the last 12 months), there
was a very high probability (>90%) that the respective drugs were
used simultaneously.
While alcohol use was evident in every cluster, the groups
showed unique features in both the prominence of particular drug
types and the breadth of drugs used. Class 2 was characterized by
high probabilities of alcohol and tobacco use. Class 3 was charac-
terized by a limited breadth of drugs used, and the use of two illicit
drug types – cannabis and ecstasy. Class 4 was characterized by a
similar breadth of drug type use, and was unique in terms of its
high probability of meth/amphetamine use. Class 5 was unique in
that the breadth of drug types was narrow, and this was the only
class to have a high probability of sedative use.
In some earlier research (based on different age groups and
from other countries), cluster analytic approaches have tended to
identify clusters that primarily vary in the breadth of substance
uses (i.e., clusters frequently characterized by minimal, limited, or
extended use of different substances). The present findings suggest
that, at least in the present sample, variability in high probability
substances is limited (between two and five substances, including
alcohol), and that several classes are characterized by“spikes”(high
and unique probabilities for particular drugs) (see Figure 1). These
two observations suggest that polydrug use clusters are not sim-
ply groupings based on increasing “deviance” in relation to drug
use (i.e., subgroups representing those who have progressively
expanded their field of preferred substances). Though beyond the
scope of this research, the findings point to the possibility that cer-
tain subgroups prefer certain combinations of drugs or that there
are restraints or sanctions on the use of particular drugs outside
the clusters established in this study. For example, subgroups may
have positive and negative attitudes about certain drugs based on
their legal status (accounting for the split of alcohol/alcohol and
tobacco from other classes), the acceptability of common routes of
administration [inhaling versus oral ingestion; (47)], or the per-
ceived instrumental properties of particular drug types (e.g., to
increase sociability, reduce anxiety). Further research is needed
on mechanisms that may account for clustered use of particular
drugs in nationally representative samples. The reasons why par-
ticular drugs cluster together may vary across subgroups or within
subgroups.
Predictors of class membership (relative to the alcohol cluster)
indicated consistent and relatively strong odd ratios for sex (being
female less likely to be associated with polydrug use and this was
significant for all clusters), non-completion of high school (for
all except the Sedative and alcohol class), low income (associated
with lower likelihood of polydrug use), and peer use of alco-
hol/tobacco/cannabis (consistently predicted membership of all
clusters). There were weak or inconsistent effects for age, remote-
ness (though outer regional participants were less likely to be in
clusters 3 and 4), marital status, and depressed mood. The odds
of cluster membership relative to the alcohol group were generally
non-significant for employment status and socioeconomic disad-
vantage (measured using a community-level government index).
The effects for general health were in the expected directions (clus-
ters 2–5 reporting lower health), although poor health ratings
mostly did not reach statistical significance. In sum, polydrug use
was generally associated with being male, having a very low educa-
tion (high school not completed), having a high income relative to
those on a low income, and having a peer group where the majority
use alcohol, tobacco, or marijuana.
The secondary analyses exploring simultaneous use of drugs
increased our confidence in the polydrug classes identified in the
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LCA. The percentage of concurrent users who also use simulta-
neously was high, depending on drug pair endorsements. In line
with previous studies [e.g., Ref. (26, 33, 34)], alcohol was simulta-
neously used with a wide variety of other drugs (notably cannabis,
ecstasy, meth/amphetamine, cocaine; all ≥89%). Less commonly
used together were cannabis and cocaine, cocaine and ecstasy, and
alcohol and painkillers, though prevalence within concurrent users
was still high (47–55%). The high rates of simultaneous use of par-
ticular drug pairs points to the possibility that certain drugs are
commonly used for their synergistic effects [e.g., stimulants used
to reduce the depressant effects of alcohol; (23, 24, 48, 49)], or that
craving for one drug type may increase cravings for another (50),
or that supply chains increase the probability of expansion into
other drug types.
The findings have important implications for prevention and
early intervention programs and policies relating to young adult
drug use. First, the clustering of alcohol and tobacco for a large
minority of the sample points to the possibility that alcohol use
is a high risk context for tobacco use (51). Though beyond the
scope of this study, there is good evidence that alcohol consump-
tion may erode smoking cessation attempts in young people (52),
so smoking prevention programs may benefit from an increased
focus on the risks of alcohol use. Second, the findings assist in the
relative weighting of prevention strategies based on the prevalence
of polydrug classes. It is clear that a substantial minority (approx-
imately 12%) of young adults are concurrent users of several drug
types, including cannabis, ecstasy, alcohol, and to a smaller extent
meth/amphetamines. At least in Australia, the use of ampheta-
mine derivatives (including ecstasy) is comparatively rare in the
teenage years, so a focus on the risks associated with amphetamine
derivatives (and simultaneous use of other drugs) upon reaching
young adult may be useful in stemming the apparent expansion
in the use of these drug types. Third, the proportion of young
adults who use sedatives and alcohol is small but meaningful, and
reinforces the importance of screening and surveillance strate-
gies to detect vulnerable young adults, and strategies to reduce
the inherent risks in combining sedatives and alcohol (Table 3).
Finally, young adult males with low education were at elevated
risk of poly drug use, pointing to the value of prevention pro-
grams instituted prior to the upper levels of high school and
programs for young males made available in higher paid working
environments.
The use of national surveys such as the NDSHS provides a large
sample of cross-sectional overview of drug use in the general pop-
ulation. However, the sampling of individuals with a fixed home
address or landline can fail to capture high risk young people,
such as those in transient accommodation. This may lead to an
underestimation of the actual rates of polydrug use in this group
(53, 54). Because this was a cross-sectional survey, no conclu-
sions can be made about mechanisms linking the use of different
drugs, or the factors that may underlie cluster membership. It
remains unclear whether people in particular polydrug classes have
communalities in the development of their drug use profiles, or
whether some classes merely represent a continuum of severity.
This study did not involve measures of quantity or harm, and it
is likely that only a very small proportion of this sample had any
form of drug dependence. Therefore, results may not generalize
to groups with more significant drug problems. The study relies
on self-report, although the confidential and anonymous nature
of participation is likely to have reduced response bias. Although
the overall sample size of this study was large, the sample sizes
in the class “Cannabis, amphetamine, derivatives and illicit drugs”
and “sedatives and alcohol” were relatively small and this limited
the power to identify covariates that were associated with these
two classes. Given the large number of possible permutation of
simultaneous drug use, we only examined the prevalence of spe-
cific drug pairs. Lastly, due to the limitations of the survey design,
we were not able to examine simultaneous use tobacco with other
drugs.
CONCLUSION
While the sole use of alcohol characterized most people in the sam-
ple, a substantial minority of young adults were concurrent users
of several drug types. Young adults clustered on unique combina-
tions of alcohol, tobacco, cannabis, ecstasy, meth/amphetamine,
and sedatives. Simultaneous use of two substances was charac-
teristic of concurrent users. Peer use of alcohol, tobacco, and
cannabis were significant correlates of young adult polydrug use.
Young males with low education and/or higher income are a
high risk group that warrant a prevention and early intervention
focus.
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